Efficacy of Surufatinib in Western Patients (pts) with Pancreatic Neuroendocrine Tumors (PanNETs)

被引：0
作者：
Dasari, A. [1 ]
Paulson, S. [2 ]
Sung, M. [3 ]
Tucci, C. [4 ]
Kauh, J. [4 ]
Kania, M. [4 ]
Li, D. [5 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Baylor Charles A Sammons Canc Ctr Texas Oncol, Dallas, TX USA
[3] Mt Sinai Hosp, New York, NY USA
[4] Hutchison MediPharma Int Inc, Florham Pk, NJ USA
[5] City Hope Canc Ctr, Duarte, CA USA
来源：
NEUROENDOCRINOLOGY | 2020年 / 110卷
关键词：
neuroendocrine tumors; pancreatic; surufatinib;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I02
引用
收藏
页码：209 / 209
页数：1
相关论文
共 50 条
  • [41] Medical management of pancreatic neuroendocrine tumors in patients with MEN 1: case report
    Mohammad Reza Mohajeri-Tehrani
    Mahbube Ebrahimpur
    Siavosh Nasseri-Moghaddam
    Seyed-Mohammad Tavangar
    Mahnaz Pejman Sani
    Abdollah Zandi
    Mohammad Behgam Shadmehr
    Journal of Diabetes & Metabolic Disorders, 2022, 21 : 2009 - 2011
  • [42] Update on Novel Therapies for Pancreatic Neuroendocrine Tumors
    Oberstein, Paul Eliezer
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2012, 13 (04): : 372 - 375
  • [43] Contemporary Management of Nonfunctioning Pancreatic Neuroendocrine Tumors
    Minter, Rebecca M.
    Simeone, Diane M.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (02) : 435 - 446
  • [44] Small pancreatic neuroendocrine tumors: Resect or enucleate?
    Beane, Joal D.
    Borrebach, Jeffrey D.
    Billderback, Andrew
    Onuma, Amblessed E.
    Adam, Mohamed A.
    Zureikat, Amer H.
    Pitt, Henry A.
    AMERICAN JOURNAL OF SURGERY, 2021, 222 (01) : 29 - 34
  • [45] Pancreatic Neuroendocrine Tumors: Entering a New Era
    Oberstein, Paul E.
    Remotti, Helen
    Saif, Muhammad Wasif
    Libutti, Steven K.
    JOURNAL OF THE PANCREAS, 2012, 13 (02): : 169 - 173
  • [46] Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity
    Antonodimitrakis, Pantelis Clewemar
    Sundin, Anders
    Wassberg, Cecilia
    Granberg, Dan
    Skogseid, Britt
    Eriksson, Barbro
    NEUROENDOCRINOLOGY, 2016, 103 (3-4) : 345 - 353
  • [47] Efficacy and safety of surufatinib in the treatment of advanced solid tumors: a systematic evaluation and meta-analysis
    Cai, Tianying
    Cheng, Yonglang
    Du, Yichao
    Tan, Peng
    Li, Tongxi
    Chen, Yifan
    Gao, Lin
    Fu, Wenguang
    ONCOLOGY LETTERS, 2023, 25 (06)
  • [48] High efficacy of combined PRRT and CAPTEM therapy based on objective response rate (RECIST) in patients with pancreatic and midgut neuroendocrine tumors (NET)
    Kolasinska-Cwikla, A.
    Nowicki, M.
    Zrajkowska, A.
    Palucki, J.
    Nowicka, G.
    Seklecka, N.
    Cwikla, J. B.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 188 - 188
  • [49] Gemcitabine as Salvage Treatment in Patients with Poorly Differentiated Pancreatic Neuroendocrine Tumors: A Case Series
    Saif, Muhammad Wasif
    Kaley, Kristin
    Rodriguez, Teresa
    Garcon, Marie Carmel
    JOURNAL OF THE PANCREAS, 2014, 15 (01): : 38 - 41
  • [50] Occurrence of exocrine pancreatic insufficiency in patients with advanced neuroendocrine tumors treated with somatostatin analogs
    Rinzivillo, Maria
    De Felice, Ilaria
    Magi, Ludovica
    Annibale, Bruno
    Panzuto, Francesco
    PANCREATOLOGY, 2020, 20 (05) : 875 - 879
12345